Diagnosis of parkinsonism in older patients receiving sodium valproate [7]

Movement Disorders

Volumn 22, Issue 8, 2007, Pages 1211-

  Macphee, Graeme J A ^a   Stewart, David A ^b  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; CO BENELDOPA; DIAZEPAM; MIRTAZAPINE; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM;

ABDOMINAL PAIN; AGED; BRADYKINESIA; BRAIN ATROPHY; CASE REPORT; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DRUG INDUCED DISEASE; FACIAL EXPRESSION; FECES IMPACTION; FEMALE; HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; SEIZURE; SPEECH DISORDER; TREMOR;

AGED; DEPRESSION; FEMALE; HUMANS; PARKINSONIAN DISORDERS; SEIZURES; VALPROIC ACID;

EID: 34447520133     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21514     Document Type: Letter

References (6)

1. Jamora D, Lim S-H, Pan A, et al. Valproate induced Parkinsonism in epilepsy patients. Mov Disord 2007;22:130-133.
2. Armon C, Sin C, Miller P, et al. Reversible Parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996; 47:626-635.
3. Marshall V, Grosset DG. Role of dopamine transporter imaging in atypical tremor syndromes. Mov Disord 2003;18 (Suppl 7):S22-S27.
4. Easterford K, Clough P, Kellet M, et al. Reversible Parkinsonism with normal FP CIT SPECT in patients exposed to sodium valproate. Neurology 2004;62:1435-1437.
5. Macphee GJA. Image of the quarter: valproate induced Parkinsonism. J R Coll Physicians Edinb 2005;35:214-216.
6. Perucca E, Aldenkamp A, Tallis R, Kramer G. Role of valproate across the ages: treatment of epilepsy in the elderly. Acta Neurol Scand 2006;114 (Suppl 184):28-37.